| Literature DB >> 33510165 |
Huai-Bin Hu1, Zeng-Qing Song1, Guang-Ping Song1, Sen Li1, Hai-Qing Tu1, Min Wu1, Yu-Cheng Zhang1, Jin-Feng Yuan1, Ting-Ting Li1, Pei-Yao Li1, Yu-Ling Xu1, Xiao-Lin Shen1, Qiu-Ying Han1, Ai-Ling Li1, Tao Zhou1, Jerold Chun2, Xue-Min Zhang3, Hui-Yan Li4,5.
Abstract
Dynamic assembly and disassembly of primary cilia controls embryonic development and tissue homeostasis. Dysregulation of ciliogenesis causes human developmental diseases termed ciliopathies. Cell-intrinsic regulatory mechanisms of cilia disassembly have been well-studied. The extracellular cues controlling cilia disassembly remain elusive, however. Here, we show that lysophosphatidic acid (LPA), a multifunctional bioactive phospholipid, acts as a physiological extracellular factor to initiate cilia disassembly and promote neurogenesis. Through systematic analysis of serum components, we identify a small molecular-LPA as the major driver of cilia disassembly. Genetic inactivation and pharmacological inhibition of LPA receptor 1 (LPAR1) abrogate cilia disassembly triggered by serum. The LPA-LPAR-G-protein pathway promotes the transcription and phosphorylation of cilia disassembly factors-Aurora A, through activating the transcription coactivators YAP/TAZ and calcium/CaM pathway, respectively. Deletion of Lpar1 in mice causes abnormally elongated cilia and decreased proliferation in neural progenitor cells, thereby resulting in defective neurogenesis. Collectively, our findings establish LPA as a physiological initiator of cilia disassembly and suggest targeting the metabolism of LPA and the LPA pathway as potential therapies for diseases with dysfunctional ciliogenesis.Entities:
Year: 2021 PMID: 33510165 PMCID: PMC7843646 DOI: 10.1038/s41467-021-20986-y
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919